Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Blog
Blog Library
Upcoming catalysts, a New Year’s celebration for some
Got 10 minutes? Grab a coffee and listen to our latest podcast looking at the latest and upcoming readouts to see what's going to be hot as we head into 2023.
Evaluating the London Marathon
Running a marathon is never easy, but the right motivation (and peanut butter) certainly help.
Meet the Evaluate Team: Christina Kay
Behind Evaluate’s data and insights about the biopharma space, there are people who work to make sure that our clients have everything they need to make their lives a…
Meet the Evaluate Team: Cem Baydar
Evaluate may be a business founded on great data and insights, but it’s the people that make the magic happen. In this new blog series, we’ll introduce the people behind…
Medtech in 2028: Suffering or celebrating a Covid hangover?
We've extended our forecasts out to 2028 and in our latest report, we take a look at what's in store for the medtech market in the next few years.
Five things you’re getting wrong in your pipeline planning
R&D pipelines are the lifeblood of the pharma industry - so why are we still getting it wrong?
Evaluate Vantage Podcast: Glimmers of Hope or Fool's Gold?
The Evaluate Vantage team have hit the podcast studio again to discuss the good, the bad and the ugly of the pharma and medtech world
Patient centricity: the unexpected legacy of Covid-19
The world is a long way from understanding the true and far-reaching legacy of Covid-19. While debate regarding the handling of the pandemic will continue, there are…
Demystifying AI: Natural Language Processing (Part Two)
Natural language processing (NLP) is a key component of many machine learning approaches. We've looked at (broadly) how it works, now we investigate some of they key…